BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20925530)

  • 1. Elevated cervical white blood cell infiltrate is associated with genital HIV detection in a longitudinal cohort of antiretroviral therapy-adherent women.
    Henning TR; Kissinger P; Lacour N; Meyaski-Schluter M; Clark R; Amedee AM
    J Infect Dis; 2010 Nov; 202(10):1543-52. PubMed ID: 20925530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy.
    Si-Mohamed A; Kazatchkine MD; Heard I; Goujon C; Prazuck T; Aymard G; Cessot G; Kuo YH; Bernard MC; Diquet B; Malkin JE; Gutmann L; Bélec L
    J Infect Dis; 2000 Jul; 182(1):112-22. PubMed ID: 10882588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women.
    Tuomala RE; O'Driscoll PT; Bremer JW; Jennings C; Xu C; Read JS; Matzen E; Landay A; Zorrilla C; Blattner W; Charurat M; Anderson DJ;
    J Infect Dis; 2003 Feb; 187(3):375-84. PubMed ID: 12552421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load.
    Celum CL; Buchbinder SP; Donnell D; Douglas JM; Mayer K; Koblin B; Marmor M; Bozeman S; Grant RM; Flores J; Sheppard HW
    J Infect Dis; 2001 Jan; 183(1):23-35. PubMed ID: 11106536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts.
    Coleman JS; Hitti J; Bukusi EA; Mwachari C; Muliro A; Nguti R; Gausman R; Jensen S; Patton D; Lockhart D; Coombs R; Cohen CR
    AIDS; 2007 Mar; 21(6):755-9. PubMed ID: 17413697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding.
    Graham SM; Holte SE; Peshu NM; Richardson BA; Panteleeff DD; Jaoko WG; Ndinya-Achola JO; Mandaliya KN; Overbaugh JM; McClelland RS
    AIDS; 2007 Feb; 21(4):501-7. PubMed ID: 17301569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of human immunodeficiency virus cervicovaginal shedding among postmenopausal and fertile-aged women.
    Melo KC; Melo MR; Ricci BV; Segurado AC
    Menopause; 2012 Feb; 19(2):150-6. PubMed ID: 21983010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission.
    Panther LA; Tucker L; Xu C; Tuomala RE; Mullins JI; Anderson DJ
    J Infect Dis; 2000 Feb; 181(2):555-63. PubMed ID: 10669339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent HIV RNA shedding in semen despite effective antiretroviral therapy.
    Sheth PM; Kovacs C; Kemal KS; Jones RB; Raboud JM; Pilon R; la Porte C; Ostrowski M; Loutfy M; Burger H; Weiser B; Kaul R;
    AIDS; 2009 Sep; 23(15):2050-4. PubMed ID: 19710596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years.
    Günthard HF; Havlir DV; Fiscus S; Zhang ZQ; Eron J; Mellors J; Gulick R; Frost SD; Brown AJ; Schleif W; Valentine F; Jonas L; Meibohm A; Ignacio CC; Isaacs R; Gamagami R; Emini E; Haase A; Richman DD; Wong JK
    J Infect Dis; 2001 May; 183(9):1318-27. PubMed ID: 11294662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women.
    Shaheen F; Sison AV; McIntosh L; Mukhtar M; Pomerantz RJ
    J Hum Virol; 1999; 2(3):154-66. PubMed ID: 10413367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual HIV-1 RNA and HIV-1 DNA production in the genital tract reservoir of women treated with HAART: the prospective ANRS EP24 GYNODYN study.
    Launay O; Tod M; Tschöpe I; Si-Mohamed A; Bélarbi L; Charpentier C; Goujard C; Taburet AM; Lortholary O; Leroy V; Bélec L;
    Antivir Ther; 2011; 16(6):843-52. PubMed ID: 21900716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive women.
    Uvin SC; Caliendo AM
    Obstet Gynecol; 1997 Nov; 90(5):739-43. PubMed ID: 9351756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy.
    Zhang H; Dornadula G; Beumont M; Livornese L; Van Uitert B; Henning K; Pomerantz RJ
    N Engl J Med; 1998 Dec; 339(25):1803-9. PubMed ID: 9854115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent observations on HIV type-1 infection in the genital tract of men and women.
    Coombs RW; Reichelderfer PS; Landay AL
    AIDS; 2003 Mar; 17(4):455-80. PubMed ID: 12598766
    [No Abstract]   [Full Text] [Related]  

  • 16. Frequent detection of HIV-1 RNA but low rates of HIV-1 isolation in cervicovaginal secretions from infected women.
    Saracino A; Di Stefano M; Fiore JR; Lepera A; Raimondi D; Angarano G; Pastore G
    New Microbiol; 2000 Jan; 23(1):79-83. PubMed ID: 10946409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract.
    Cu-Uvin S; Hogan JW; Caliendo AM; Harwell J; Mayer KH; Carpenter CC;
    Clin Infect Dis; 2001 Sep; 33(6):894-6. PubMed ID: 11512096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectivity and dynamics of HIV type 1 replication in the blood and reproductive tract of HIV type 1-infected women.
    Rasheed S
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S105-18. PubMed ID: 9581894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
    Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
    Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.
    Furtado MR; Callaway DS; Phair JP; Kunstman KJ; Stanton JL; Macken CA; Perelson AS; Wolinsky SM
    N Engl J Med; 1999 May; 340(21):1614-22. PubMed ID: 10341273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.